An updated overview of e-cigarette impact on human health.

Autores de INCLIVA
Grupos y Plataformas de I+D+i
Abstract
The electronic cigarette (e-cigarette), for many considered as a safe alternative to conventional cigarettes, has revolutionised the tobacco industry in the last decades. In e-cigarettes, tobacco combustion is replaced by e-liquid heating, leading some manufacturers to propose that e-cigarettes have less harmful respiratory effects than tobacco consumption. Other innovative features such as the adjustment of nicotine content and the choice of pleasant flavours have won over many users. Nevertheless, the safety of e-cigarette consumption and its potential as a smoking cessation method remain controversial due to limited evidence. Moreover, it has been reported that the heating process itself can lead to the formation of new decomposition compounds of questionable toxicity. Numerous in vivo and in vitro studies have been performed to better understand the impact of these new inhalable compounds on human health. Results of toxicological analyses suggest that e-cigarettes can be safer than conventional cigarettes, although harmful effects from short-term e-cigarette use have been described. Worryingly, the potential long-term effects of e-cigarette consumption have been scarcely investigated. In this review, we take stock of the main findings in this field and their consequences for human health including coronavirus disease 2019 (COVID-19).
Datos de la publicación
- ISSN/ISSNe:
- 1465-9921, 1465-993X
- Tipo:
- Article
- Páginas:
- 151-151
- PubMed:
- 34006276
RESPIRATORY RESEARCH BIOMED CENTRAL LTD
Citas Recibidas en Web of Science: 247
Documentos
Filiaciones
Keywords
- COVID-19; E-cigarette; Electronic cigarette; Flavourings; Humectants; Nicotine; Smoking cessation tool; Tobacco; Toxicity
Financiación
Proyectos y Estudios Clínicos
A multidisciplinary project to advance in basic mechanisms, diagnosis, prediction, and prevention of cardiac damage in reperfused acute myocardial infarction.
Investigador Principal: VICENT BODÍ PERIS
PIE15/00013 . INSTITUTO SALUD CARLOS III . 2016
RETOS 2017. MODULACION FARMACOLOGICA DEL SISTEMA INMUNE COMO DIANA CLAVE EN LA PREVENCION DE LA ENFERMEDAD CARDIOVASCULAR ASOCIADA A DESORDENES METABOLICOS. SINTESIS DE FARMACOS NOVEDOSOS
Investigador Principal: MARIA JESUS SANZ FERRANDO
SAF2017-89714-R . MINISTERIO ECONOMIA Y COMPETITIVIDAD . 2018
Identificación de nuevos mecanismos implicados en la angiogénesis e inflamación en pacientes obesos. Modulación por ligandos de receptores nucleares constitutivos de androstano.
Investigador Principal: JOSE TOMAS REAL COLLADO
PI18/00209 . INSTITUTO SALUD CARLOS III . 2019
Efecto de la cirugía bariátrica en la inflamación vascular en pacientes con obesidad morbida y diabéticos.
Investigador Principal: LAURA PIQUERAS RUIZ
AICO/2019/250 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2019
'Una aproximación translacional desde la clínica a la experimentación animal: Estudio del papel del eje CCL11/CCR3 y la inflamación eosinofílica en la patología cardiovascular asociada a desórdenes metabólicos. -
Investigador Principal: MARIA JESUS SANZ FERRANDO
PROMETEO2019/032 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2020
CDEI-04/20-A GENT LAURA PIQUERAS (2019/200) CONTRATO
Investigador Principal: LAURA PIQUERAS RUIZ
2019/200C . CONSELLERIA DE SANIDAD
Cita
Marques P,Piqueras L,Sanz MJ. An updated overview of e-cigarette impact on human health. Respir. Res. 2021. 22. (1):p. 151-151. IF:7,162. (1).
An updated overview of e-cigarette impact on human health. Marques P, Piqueras L, Sanz MJ. RESPIRATORY RESEARCH. 2021 mayo 18. 22 (1):151-151. DOI:10.1186/s12931-021-01737-5. PMID:34006276.